Shawn (Xiangyu) Pan

A Ph.D of bioinformatics

• To investigate the epigenetics reprogramming mechanisms in tumorigenesis and tumor-maintenance
• To build the bridge from wet-hands and dry-hands and establish novel omics analysis platform
• To build the molecular bridge between the mouse models and human diseases by omics data analyzing

Shawn (Xiangyu) Pan

Shawn (Xiangyu) Pan

Ph.D of bioinformatics

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China

Introduction

  I’m Xiangyu Pan, also could call me Shawn, a senior bioinformatician that skillful in omics data analyzing, including single-cell RNA, ATAC and spatial data, bulk RNA and ATAC data, CUT&Tag-seq (ChIP-seq) data and WGBS-seq data. During my PhD training, I have a good grasp of epigenetics biology and I’m so passionate in unraveling the epigenetics reprogramming mechanisms in tumorigenesis and tumor-maintenance, especially for tumor metastasis and resistance.
  I finished three main projects during my PhD training: 1) Identifying a confused cell identity for esophageal squamous cell carcinoma; 2) KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming; 3) Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic lymphohistiocytosis in adults. Besides, I also participated in many other projects and cooperated with other lab members to reveal the tumor resistance mechanism under chemotherapy and/or immunotherapy treatment.
  As the one of the first developers to establish the bioinformatics team in our wet lab, I am capable for building the bridge from wet-hands and dry-hands, and the molecular bridge between the mouse models and human disease by omics data analyzing. And I’m so expected that I could increase my scientific taste and sense in the future research.😊

Education

 
 
 
 
 

Ph.D. in Bioinformatics

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University

Sep 2018 – Present Chengdu, China
  • Supervisor: Prof. Chong Chen and Prof. Yu Liu
  • Poster: Nivolumab treatment of relapsed/refractory Epstein-Barr virus–associated hemophagocytic Lymphohistiocytosis in adults, The 4th Young Life Scientists Forum and Research Achievement Competition, 2020, Beijing, China.
  • Speaker: Investigating the evolution of esophageal carcinoma by single cell sequencing, International Academic Forum for Doctoral Students of Sichuan University, in the Chengdu International Precision Medicine Forum, Sep. 2019, Chengdu, China.
 
 
 
 
 

B.Sc. in Chemistry

State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University

Sep 2016 – Jun 2018 Chengdu, China
  • Supervisor: Prof. Chong Chen and Prof. Lunzhi Dai
  • Teacher assistant of Frontiers in Biomedical and Pharmaceutical Researches (II)
  • Teacher assistant of Introduction to Biomedical Research
  • Teacher assistant of Advanced drug synthesis
  • Teacher assistant of Frontiers in Biomedical and Pharmaceutical Researches (I)
 
 
 
 
 

B.Sc. in Chemistry

Chemistry Department, Sichuan University

Sep 2015 – Jun 2016 Chengdu, China

Publications

Quickly discover relevant content by filtering publications.

Clinically relevant orthotopic xenograft models of patient-derived glioblastoma in zebrafish

An accurate prediction of the intracranial infiltration tendency and drug response of individual glioblastoma (GBM) cells is essential …

Striking effect of low-dose radiotherapy combined with PD-1 blockade on small cell lung cancer in mice and refractory patients (Achilles Study)

Background: Immune checkpoint inhibitors (ICIs) provide a durable and long-term benefit but still unsatisfactory clinical efficacy for …

KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming

Small cell lung cancer (SCLC) is notorious for its early and frequent metastases, which contribute to it as a recalcitrant malignancy. …

Identifying a confused cell identity for esophageal squamous cell carcinoma

The cell identity of malignant cells and how they acquire it are fundamental for our understanding of cancer. Here, we report that …

Contact